Welcome to our dedicated page for Accenture Plc Ireland SEC filings (Ticker: ACN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Accenture plc (ACN) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, including annual and quarterly financial reports, proxy materials and current reports on significant events. As a New York Stock Exchange‑listed company incorporated in Ireland, Accenture uses these filings to provide detailed information on its financial performance, governance, strategy and material developments.
Accenture’s Form 8‑K current reports frequently furnish earnings releases for quarterly and annual periods, outlining revenues, operating margin, earnings per share, bookings, free cash flow and other key metrics. These 8‑K filings also describe the company’s use of non‑GAAP measures such as free cash flow, local‑currency growth and adjusted results that exclude specified business optimization costs, along with reconciliations to GAAP figures. Other 8‑K filings disclose leadership and organizational changes, including updates to Accenture’s growth model and senior management roles.
The company’s definitive proxy statement (DEF 14A) provides extensive detail on corporate governance, board structure, director nominees, executive compensation programs, share incentive plans and shareholder proposals. It also discusses Accenture’s strategy to be the reinvention partner of choice for clients, its Reinvention Services structure, and multi‑year trends in revenue growth, margins, earnings and cash returned to shareholders.
Through this page, users can access Accenture’s 10‑K annual reports, 10‑Q quarterly reports, 8‑K current reports, proxy statements and related exhibits as they are filed with the SEC’s EDGAR system. Stock Titan enhances these documents with AI‑powered summaries that highlight the main points of lengthy filings, explain non‑GAAP reconciliations, and surface items such as compensation plans and governance proposals. Investors tracking ACN can use these filings to review historical performance, understand management’s reporting practices and monitor material events affecting the company.
A person associated with ACN has filed a notice of proposed sale of company stock under Rule 144. The planned transaction covers 1,026 Class A Ordinary shares, to be sold through UBS Financial Services, Inc. on the NYSE, with an indicated aggregate market value of $291,732.84.
The shares to be sold were acquired on 10/20/2025 as a stock award from the issuer, with the same date shown for payment and the nature of payment listed as not applicable. The filing also notes that the same person sold 1,332 Class A Ordinary shares on 01/06/2026 for gross proceeds of $366,300.00 during the prior three months, providing context on recent selling activity.
Accenture plc’s Chief Leadership & HR Officer, Katherine Lee Clifford, reported multiple open-market sales of Class A ordinary shares on January 20, 2026. The transactions were coded as sales and executed under a Rule 10b5-1 trading plan, meaning they were pre-arranged rather than discretionary. The shares were sold in several small blocks at weighted average prices ranging from about $274.19 to $284.84, with each block priced based on multiple individual trades within the stated ranges.
Following these transactions, Clifford directly held 6,788 Class A ordinary shares of Accenture and had an additional 27 shares held indirectly by an immediate family member. The filing notes that full trade-by-trade detail within each price range is available upon request from the company, the SEC staff, or a security holder.
BlackRock, Inc. has filed an amended Schedule 13G/A reporting its beneficial ownership in Accenture plc Class A stock as of 12/31/2025. BlackRock reports beneficial ownership of 51,114,360 shares, representing 8.3% of the outstanding Class A shares. It holds sole voting power over 46,800,569 shares and sole dispositive power over all 51,114,360 shares, with no shared voting or dispositive power.
The filing notes that these securities are held by certain BlackRock business units and that various underlying clients have the right to receive dividends and sale proceeds, with no single client holding more than five percent of Accenture’s outstanding common shares. BlackRock certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Accenture.
A person filing a Form 144 notice plans to sell 681 Class A Ordinary shares of the issuer through UBS Financial Services, Inc. on the NYSE. The planned sale has an aggregate market value of 192,341.00, and the issuer has 660,432,542 shares outstanding. The shares to be sold were acquired on 01/01/2026 as a stock award from the issuer, with the same date listed as the date of payment and the nature of payment marked as N/A. The approximate date of sale is listed as 01/20/2026, and the form includes the standard representation that the seller does not know of any undisclosed material adverse information about the issuer.
Accenture plc’s Chief Executive Officer-EMEA, Mauro Macchi, reported a small planned share sale. On January 14, 2026, he sold 500 Class A ordinary shares of Accenture at $280 per share in an open-market transaction coded as a sale.
The transaction was carried out under a Rule 10b5-1 trading plan, which is a pre-arranged program for buying or selling shares. After this sale, Macchi beneficially owns 7,123 Accenture Class A shares directly, according to the filing.
Accenture plc Chief Strategy & Services Officer Manish Sharma reported several open-market sales of Class A ordinary shares on January 14, 2026 under a pre-arranged Rule 10b5-1 trading plan. The transactions, all coded as sales, were executed at prices ranging from about $276.61 to $290.21 per share. After these trades, Sharma directly owned 7,057 Accenture Class A ordinary shares.
Accenture plc’s Chair and CEO, Julie Sweet, reported a planned sale of company stock. On January 14, 2026, she sold a total of 1,694 Class A ordinary shares of Accenture plc in a series of open-market transactions at prices ranging from $276.61 to $290.915 per share. The filing states these dispositions were made under a pre-established Rule 10b5-1 trading plan, which allows trades to occur according to preset instructions. After these transactions, she directly held 37,346 Class A ordinary shares of Accenture.
A Form 144 notice reports that an affiliate of ACN, Manish Sharma, plans to sell 2,731 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of $786,870.47. The issuer has 660,432,542 shares of this class outstanding.
The shares to be sold were acquired from the issuer as stock awards on multiple dates in 2025 and 2026, including a grant of 1,502 shares on 12/05/2025. The filing also notes a prior sale by Manish Sharma of 6,902 Class A Ordinary shares on 10/22/2025, for gross proceeds of $1,725,546.93.
A person named Mauro Macchi has filed a Form 144 notice to sell 500 Class A Ordinary shares of the issuer through UBS Financial Services, Inc. on the NYSE, with an approximate sale date of 01/14/2026. The aggregate market value for this planned sale is listed as 140000.00, and the issuer reports 660432542 shares outstanding.
The securities to be sold were acquired on 10/20/2025 as a stock award from the issuer, with 500 securities acquired on that date. The notice also reports that during the past three months, Mauro Macchi sold an additional 500 Class A Ordinary shares on 01/07/2026 for gross proceeds of 140000.00. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.
Julie Sweet has filed a Form 144 to sell up to 1,694 Class A Ordinary shares. The planned sale is to be executed through UBS Financial Services on the NYSE, with an aggregate market value of
The shares to be sold were acquired as stock awards from the issuer, including 158 shares on